FR3111074B1 - Composition à base de rétinol - Google Patents

Composition à base de rétinol Download PDF

Info

Publication number
FR3111074B1
FR3111074B1 FR2005957A FR2005957A FR3111074B1 FR 3111074 B1 FR3111074 B1 FR 3111074B1 FR 2005957 A FR2005957 A FR 2005957A FR 2005957 A FR2005957 A FR 2005957A FR 3111074 B1 FR3111074 B1 FR 3111074B1
Authority
FR
France
Prior art keywords
retinol
composition based
composition
hydroxycinnamate
caring
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR2005957A
Other languages
English (en)
Other versions
FR3111074A1 (fr
Inventor
Naima Yousfi
Francoise Ho
Majolie Libii
Gaetane David
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LOreal SA
Original Assignee
LOreal SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR2005957A priority Critical patent/FR3111074B1/fr
Application filed by LOreal SA filed Critical LOreal SA
Priority to KR1020227039202A priority patent/KR20220167310A/ko
Priority to US17/905,190 priority patent/US20230104881A1/en
Priority to EP21730237.1A priority patent/EP4161478A1/fr
Priority to PCT/EP2021/065310 priority patent/WO2021250008A1/fr
Priority to CN202180040557.6A priority patent/CN115867252A/zh
Priority to JP2022574813A priority patent/JP2023529178A/ja
Publication of FR3111074A1 publication Critical patent/FR3111074A1/fr
Application granted granted Critical
Publication of FR3111074B1 publication Critical patent/FR3111074B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/347—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • A61K8/375—Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/676—Ascorbic acid, i.e. vitamin C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/678—Tocopherol, i.e. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/02—Preparations containing skin colorants, e.g. pigments
    • A61Q1/04—Preparations containing skin colorants, e.g. pigments for lips
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/02—Preparations containing skin colorants, e.g. pigments
    • A61Q1/10—Preparations containing skin colorants, e.g. pigments for eyes, e.g. eyeliner, mascara

Abstract

Composition à base de rétinol La présente invention concerne une composition, notamment cosmétique, en particulier de maquillage et/ou de soin des matières kératiniques, comprenant au moins du rétinol, du tétra hydroxycinnamate de di-t-butyle pentaérythrityle, un sel de l’acide éthylène diamine disuccinique, et au moins un composé choisi parmi de l’acide ascorbique ou l’un de ses analogues, et/ou du tocophérol ou l’un de ses dérivés. Figure pour l’abrégé : Néant
FR2005957A 2020-06-08 2020-06-08 Composition à base de rétinol Active FR3111074B1 (fr)

Priority Applications (7)

Application Number Priority Date Filing Date Title
FR2005957A FR3111074B1 (fr) 2020-06-08 2020-06-08 Composition à base de rétinol
US17/905,190 US20230104881A1 (en) 2020-06-08 2021-06-08 Retinol-based composition
EP21730237.1A EP4161478A1 (fr) 2020-06-08 2021-06-08 Composition à base de rétinol
PCT/EP2021/065310 WO2021250008A1 (fr) 2020-06-08 2021-06-08 Composition à base de rétinol
KR1020227039202A KR20220167310A (ko) 2020-06-08 2021-06-08 레티놀계 조성물
CN202180040557.6A CN115867252A (zh) 2020-06-08 2021-06-08 基于视黄醇的组合物
JP2022574813A JP2023529178A (ja) 2020-06-08 2021-06-08 レチノールをベースとする組成物

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR2005957 2020-06-08
FR2005957A FR3111074B1 (fr) 2020-06-08 2020-06-08 Composition à base de rétinol

Publications (2)

Publication Number Publication Date
FR3111074A1 FR3111074A1 (fr) 2021-12-10
FR3111074B1 true FR3111074B1 (fr) 2022-07-01

Family

ID=72885646

Family Applications (1)

Application Number Title Priority Date Filing Date
FR2005957A Active FR3111074B1 (fr) 2020-06-08 2020-06-08 Composition à base de rétinol

Country Status (7)

Country Link
US (1) US20230104881A1 (fr)
EP (1) EP4161478A1 (fr)
JP (1) JP2023529178A (fr)
KR (1) KR20220167310A (fr)
CN (1) CN115867252A (fr)
FR (1) FR3111074B1 (fr)
WO (1) WO2021250008A1 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023076543A1 (fr) * 2021-10-31 2023-05-04 L'oreal Compositions cosmétiques comprenant des quantités élevées de rétinol
FR3132218A1 (fr) * 2022-01-31 2023-08-04 L'oreal Compositions cosmétiques comprenant des quantités élevées de rétinol
WO2023102894A1 (fr) * 2021-12-10 2023-06-15 L'oreal Composition pour stabiliser des principes actifs
FR3130598A1 (fr) * 2021-12-17 2023-06-23 L'oreal Composition cosmétique ou dermatologique comprenant une mérocyanine et du tétra hydroxycinnamate de di-t-butyle pentaérythrityle
FR3130596A1 (fr) * 2021-12-17 2023-06-23 L'oreal Composition cosmétique et/ou dermatologique comprenant au moins une mérocyanine et au moins de l’acide ascorbique et/ou l’un de ses dérivés
FR3131837A1 (fr) * 2022-01-19 2023-07-21 L'oreal Composition stable comprenant un rétinoïde et un composé acide ascorbique
WO2023120390A1 (fr) * 2021-12-20 2023-06-29 L'oreal Composition stable comprenant un rétinoïde et un composé d'acide ascorbique
CN114917145A (zh) * 2022-04-21 2022-08-19 蓓悠清(广东)健康科技有限公司 一种美白抗皱组合物及其应用
WO2024045049A1 (fr) * 2022-08-31 2024-03-07 L'oreal Composition pour le soin des matières kératiniques et masque la contenant

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR853634A (fr) 1938-04-29 1940-03-23 Ericsson Telefon Ab L M Appareils de mesure
JPS53128333A (en) 1977-04-15 1978-11-09 Fuji Photo Film Co Ltd Prevention of influences of ultraviolet ray upon photosensitive material of silver halogenide
DE8322682U1 (de) 1983-08-05 1986-02-13 Siemens AG, 1000 Berlin und 8000 München Mechanische Überlastungssicherung
US5624663A (en) 1987-08-28 1997-04-29 L'oreal Photostable cosmetic filter composition cotaining a UV-A filter and a substituted dialkylbenzalmalonate, the use of substituted dialkylbenzalmalonates in cosmetics as broad-band solar filters and novel substituted dialkyl malonates
JP2832848B2 (ja) 1989-10-21 1998-12-09 株式会社林原生物化学研究所 結晶２―Ｏ―α―Ｄ―グルコピラノシル―Ｌ―アスコルビン酸とその製造方法並びに用途
TW197375B (fr) 1990-11-19 1993-01-01 Hayashibara Biochem Lab
CA2090104C (fr) 1991-06-27 2002-05-28 Charles E. Clum Compositions pour soins de la peau, a base de retinoide stabilise
FR2680683B1 (fr) 1991-08-29 1993-11-12 Oreal Composition cosmetique filtrante contenant un polymere filtre a structure hydrocarbonee et une silicone filtre.
WO1996007396A2 (fr) 1994-09-07 1996-03-14 Johnson & Johnson Consumer Products, Inc. Compositions a base de retinoides
IT1284525B1 (it) 1996-09-13 1998-05-21 3V Sigma Spa Derivati di benzossazolo loro uso come stabilizzanti contro le radiazioni uv
DE19755649A1 (de) 1997-12-15 1999-06-17 Basf Ag Photostabile UV-Filter enthaltende kosmetische und pharmazeutische Zubereitungen
DE19746654A1 (de) 1997-08-13 1999-02-18 Basf Ag Photostabile UV-Filter enthaltende kosmetische und pharmazeutische Zubereitungen
DE19828463A1 (de) 1998-06-26 1999-12-30 Basf Ag 4,4-Diarylbutadiene als wasserlösliche photostabile UV-Filter für kosmetische und pharmazeutische Zubereitungen
DE19855649A1 (de) 1998-12-03 2000-06-08 Basf Ag Dimere alpha-Alkyl-Styrolderivate als photostabile UV-Filter in kosmetischen und pharmazeutischen Zubereitungen
DE19857127A1 (de) 1998-12-11 2000-06-15 Basf Ag Oligomere Diarylbutadiene
IT1312374B1 (it) 1999-01-11 2002-04-15 3V Sigma Spa Associazioni di filtri solari e composizioni cosmetiche che licontengono
DE10012408A1 (de) 2000-03-15 2001-09-20 Basf Ag Verwendung von Lichtschutzmittelkombinationen, die als wesentlichen Bestandteil aminosubstituierte Hydroxybenzophenone enthalten als photostabile UV-Filter in kosmetischen und pharmazeutischen Zubereitungen
ITMI20012037A1 (it) 2001-10-02 2003-04-02 3V Sigma Spa Associazioni di filtri solari
DE10162844A1 (de) 2001-12-20 2003-07-03 Beiersdorf Ag Kosmetische und dermatologische Lichtschutzformulierungen mit einem Gehalt an Bis-Resorcinyltriazinderivaten und Benzoxazol-Derivaten
JP3854524B2 (ja) * 2002-04-01 2006-12-06 ピアス株式会社 油溶性成分安定化組成物及びその組成物を配合した化粧料、並びに油溶性成分の安定化方法
KR101043995B1 (ko) 2002-07-10 2011-06-24 시바 홀딩 인코포레이티드 화장품용 메로시아닌 유도체
JP2004175731A (ja) * 2002-11-28 2004-06-24 Noevir Co Ltd 老化防止用皮膚外用剤
DE102004003478A1 (de) * 2004-01-22 2005-08-18 Basf Ag Retinoid-haltige Zubereitungen
CN101182299A (zh) * 2006-07-31 2008-05-21 赛德玛公司 新的酪胺衍生物,其制备方法及其化妆品或皮肤药物组合物
US8535648B2 (en) 2007-01-25 2013-09-17 Basf Se Stabilization of UV-sensitive active ingredients
WO2008155059A2 (fr) 2007-06-19 2008-12-24 Cognis Ip Management Gmbh Mélanges d'hydrocarbures et leur utilisation
BRPI0816128B1 (pt) 2007-08-24 2016-10-11 Basf Se uso de uma composição de estabilização, e, composição de estabilização
CN102883704A (zh) 2010-03-15 2013-01-16 莱雅公司 含有二苯甲酰甲烷掩蔽剂和亲水性或水溶性部花青紫外掩蔽剂的组合物、用于使所述二苯甲酰甲烷掩蔽剂光稳定化的方法
KR102177420B1 (ko) * 2017-04-28 2020-11-11 로토 세이야쿠 가부시키가이샤 화장료 조성물

Also Published As

Publication number Publication date
FR3111074A1 (fr) 2021-12-10
JP2023529178A (ja) 2023-07-07
KR20220167310A (ko) 2022-12-20
CN115867252A (zh) 2023-03-28
WO2021250008A1 (fr) 2021-12-16
US20230104881A1 (en) 2023-04-06
EP4161478A1 (fr) 2023-04-12

Similar Documents

Publication Publication Date Title
FR3111074B1 (fr) Composition à base de rétinol
MA42678B1 (fr) Nouveaux analogues nucléosidiques substitués à cycle aromatique bicyclique 6-6 pour une utilisation en tant qu'inhibiteurs de prmt5
TNSN07305A1 (fr) Agonistes de pyy et leurs utilisations
MA27725A1 (fr) Benzopyrannes utiles pour le traitement d'etats inflammatoires
MA30778B1 (fr) Derives de sulfonamides servant d'agonistes adrenergique et d'antagonistes muscariniques
MA42109A (fr) Amides hétérocycliques utilisés en tant qu'inhibiteurs de kinase
MA55131B1 (fr) Nouveaux composés hétérocycliques
WO2005123703A8 (fr) Nouveauc derives alkynyl servant de modulateurs de recepteurs de glutamate metabotropiques
MA49126B1 (fr) Dérivés de phényle utilisés en tant que modulateurs des récepteurs des pge2
MA29411B1 (fr) 1h-quinazoline -2,4-diones et leur utilisation en tant que ligands du recepteur ampa
FR3088548B1 (fr) Composition comprenant un derive d’acide cinnamique et un polymere cellulosique non ionique non associatif
MA43409B1 (fr) Composés polycycliques à utiliser en tant qu'inhibiteurs de la tyrosine kinase de bruton
MA32455B1 (fr) Oxazolopyrimidines en tant qu'agonistes des récepteurs edg-1
MA35158B1 (fr) Formulations topiques de type suspension comprenant un depsipeptide cyclique
FR3111075B1 (fr) Composition à base de rétinol
FR3104975B1 (fr) Composition à base de rétinol
MA55821B1 (fr) Antagonistes 5-ht2a destinés à être utilisés dans le traitement de la dépression
MA38410A1 (fr) Composés d'azétidinyloxyphénylpyrrolidine
MA29408B1 (fr) Derives d'aminoacides
FR2956811B1 (fr) Composition cosmetique anti-pelliculaire a base d'acide ellagique ou d'un de ses derives et d'un second compose actif different dans un rapport ponderal particulier.
FR3091872B1 (fr) Complexe de gadolinium et d’un ligand chelateur derive de pcta diastereoisomeriquement enrichi et procede de synthese
FR3070831B1 (fr) Procede de preparation d'une composition a base de proteines de legumineuses
FR3102178B1 (fr) Polyamides gélifiants biosourcés
MXPA06000636A (es) Formulaciones semi-solidas para la administracion oral de taxoides.
FR3104976B1 (fr) Composition à base de rétinol

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 2

PLSC Publication of the preliminary search report

Effective date: 20211210

PLFP Fee payment

Year of fee payment: 3

PLFP Fee payment

Year of fee payment: 4

PLFP Fee payment

Year of fee payment: 5